NIAID Site Search

Opportunistic fungal infections represent major causes of morbidity and mortality despite the administration of antifungal therapy. A better mechanistic understanding of host-fungal interactions will inform the development of improved immune-based strategies for the prevention, risk stratification, prognostication, vaccination, and treatment of vulnerable patient populations. In the Fungal

Last Reviewed: February 18, 2025

This document outlines the guidelines for the diagnosis and management of food allergy in the US, specifically for patients, families, and caregivers.

Last Reviewed: July 9, 2019

Epithelial Therapeutics Unit – work on the interface of environment, the microbiome, and allergic disease

Last Reviewed: September 26, 2022

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018

Learn how to interpret your NIH summary statement for information about the review, the reviewers’ critiques, and your score.

Last Reviewed: January 8, 2025

On this 35 th World AIDS Day, the National Institutes of Health (NIH) joins its partners in honoring the lives lost due to the HIV pandemic. For decades, this virus has exacted a tragic toll, affecting people, families, and communities worldwide, threatening social and economic development, and exacerbating stigma, often toward people who already experience discrimination and health disparities

Published: December 1, 2023

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024

This page explains how principal investigators using live vertebrate animals should adhere to NIH requirements, prepare applications, and manage grants.

Last Reviewed: November 21, 2024

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024